Keywords: axcan, licenses, aventis, delursan, 8m, quebec, canada-based

Axcan licenses Aventis' Delursan for $22.8M

Article | 27 January 2003

Print This

Quebec, Canada-based Axcan Pharma has acquired French rights to Delursan(ursodiol 250 mg tablets), a drug used to treat liver diseases, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in